Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
From the periphery to the brain: Lipocalin-2, a friend or foe?
Prognostic factors of acute partial transverse myelitis-reply.
Induced brain plasticity after a facilitation programme for autobiographical memory in multiple sclerosis: a preliminary study.
Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis.
Field potential recording from rat hippocampus provides a functional evaluation method for assessing demyelination and myelin repair.
Industry Update: The latest developments in therapeutic delivery.
[Update on diagnosis and treatment of multiple sclerosis.]
Unusual Manifestations of Pediatric Neuromyelitis Optica.
Features of Virchow-Robin spaces in newly diagnosed multiple sclerosis patients.
The Efficacy of Primidone in Reducing Severe Cerebellar Tremors in Patients With Multiple Sclerosis.
Intrathecal CD4(+) and CD8(+) T cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α.
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
EP2 Receptor Signaling Regulates Microglia Death.
Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis.
Modeling disease severity in multiple sclerosis using electronic health records.
The right information can transform lives.
Genetic proof for the transient nature of the Th17 phenotype.
Myelin organization in the nodal, paranodal, and juxtaparanodal regions revealed by scanning x-ray microdiffraction.
The role of transcriptional control in multiple system atrophy.
Regulation of DM-20 mRNA expression and intracellular translocation of glutathione-S-transferase pi isoform during oligodendrocyte differentiation in the adult rat spinal cord.
Neurodegeneration in multiple sclerosis: novel treatment strategies.
Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.
Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients.
Pages
« first
‹ previous
…
425
426
427
428
429
430
431
432
433
…
next ›
last »